NSAID Users Commonly Exceed Daily Limit

This article originally appeared here.
Share this content:
NSAID Users Commonly Exceed Daily Limit
NSAID Users Commonly Exceed Daily Limit

THURSDAY, Feb. 1, 2018 (HealthDay News) -- The number of users who exceed the daily limit of nonsteroidal anti-inflammatory drugs (NSAIDs) is "nontrivial," according to a study published online Jan. 26 in Pharmacoepidemiology and Drug Safety.

David W. Kaufman, Sc.D., from Boston University, and colleagues evaluated one week of online diary entries for 1,326 ibuprofen users to determine deviations from dosing directions.

The researchers found that 90 percent of diary participants took over-the-counter ibuprofen during the week, while 37 percent also took non-ibuprofen NSAIDs. Most did not recognize all products fell into the NSAID category. Eleven percent of users for ibuprofen exceeded the daily limit, as did 4 percent of users for other NSAIDs. Exceeding the daily limit was associated with male sex, ongoing pain, poor physical function, daily smoking, having the attitudes of "choosing my own dose," not starting with the lowest dose, and poor knowledge of the recommended one-time and 24-hour doses.

"The prevalence of exceeding the daily limit among NSAID users is nontrivial, and it is associated with potentially modifiable factors," the authors write. "Educating consumers about NSAIDs and their dosing directions could reduce excess dosing."

The study was sponsored by McNeil Consumer Healthcare (now Johnson & Johnson Consumer).

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »